A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells
about
Ontogeny of early life immunityMorphology, biophysical properties and protein-mediated fusion of archaeosomesNovel vaccination strategies against tuberculosis.Th17 cytokines and vaccine-induced immunity.Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonatesUnbalanced Neonatal CD4(+) T-Cell ImmunityNanomedicine in the Management of Microbial Infection - Overview and PerspectivesProtective effect of a lipid-based preparation from Mycobacterium smegmatis in a murine model of progressive pulmonary tuberculosis.Vaccine Potentiation by Combination AdjuvantsCharacterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous RoutesRapid Evolution of the CD8+ TCR Repertoire in Neonatal MiceNovel adjuvant formulations for delivery of anti-tuberculosis vaccine candidatesEffects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine AdjuvantsLiposomal vaccine delivery systems.Cationic liposomes as vaccine adjuvants.Tuberculosis vaccines in clinical trials.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis.Applications of nanotechnology for immunology.Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans.Unique aspects of the perinatal immune system.Characterization of CD31 expression on murine and human neonatal T lymphocytes during development and activation.Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.Bending elasticity modulus of giant vesicles composed of aeropyrum pernix k1 archaeal lipid.Deletion of BCG Hip1 protease enhances dendritic cell and CD4 T cell responses.Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan.The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection.Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma.CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in miceNanoparticle Vaccines Against Infectious Diseases
P2860
Q27000632-781B831B-5E4C-4F6B-943E-0299D196C728Q28481098-9412BE93-2FE4-4F4A-8415-F805A9B25EA5Q30363188-53703E84-541C-4259-9054-A48BA99914DCQ33792227-02AE69DD-69EA-4AC5-97A7-7E189087512DQ34045124-B6629776-8A03-42CC-AD84-9FC11FCA51A2Q34091987-9C47295E-9DEE-4610-A4ED-41BDC1238514Q34245494-0713E856-2369-4F58-B3BC-A21B5C72CBAFQ34762605-373E65C6-8FBC-4271-B171-35996021AD13Q35826767-6015C572-2DEC-418E-B528-3AB81D2A238BQ36002296-46CAB95A-DBAD-4FD9-977C-1AB699A8C1DAQ36655719-EA347466-DE7F-4D91-B390-6BBBD1DEEE75Q36909492-9321A7FA-8467-4B41-BD71-07F1EAE0B868Q37093487-86CCC6A0-CBD0-4399-8820-653F9617117EQ37294444-CDC436B7-9205-4DB1-9067-EEE7541AA624Q37497620-B096CA23-CBB9-4CC5-A235-40250C92C332Q37854063-6EDB32A3-CE24-48B4-8A74-846E6E6EA636Q37867105-A87F7C60-4348-4A4C-B7BC-45E4BF3EF942Q37878483-145BECBB-CF44-4EDE-956D-396B37CD0A85Q38028994-8DA2B9B0-6023-426D-B925-25F2D31D3CD7Q38110546-388DC121-18E0-420E-9C94-73E05E54C20FQ38123937-AAC995C4-A302-4E23-A18E-7D8844639FD8Q38156497-1D4F90DF-70D9-42B8-9481-F5A451B92987Q39382368-F7CEAC8E-0275-4A20-8969-77EDE44F1178Q40273643-85BFC0CE-6146-4EC3-84F3-F6F9E15C1883Q40468799-343990D4-ABE9-4E12-8B76-6E75BA0FDFF9Q41347730-0BAB9763-8412-4AB5-BF01-16B6D04D089BQ49973045-8522F1C6-06B4-4E37-81E4-763C3EE2C278Q52655234-754B22C0-D9D6-4129-9ECD-7245D3F4E16FQ54216565-25C129F0-3F87-49BE-B038-F01A33EC6270Q55293109-BF7A0679-0F1E-4D3E-B2A9-F69B92200A5EQ57955465-43454469-A48F-4027-8C33-619D5ADA02C8Q58583890-A4DFC197-FEAB-47CF-88F6-214C65122E27
P2860
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A liposome-based mycobacterial ...... e targeting of dendritic cells
@ast
A liposome-based mycobacterial ...... e targeting of dendritic cells
@en
type
label
A liposome-based mycobacterial ...... e targeting of dendritic cells
@ast
A liposome-based mycobacterial ...... e targeting of dendritic cells
@en
prefLabel
A liposome-based mycobacterial ...... e targeting of dendritic cells
@ast
A liposome-based mycobacterial ...... e targeting of dendritic cells
@en
P2093
P2860
P50
P1433
P1476
A liposome-based mycobacterial ...... e targeting of dendritic cells
@en
P2093
Anne-Françoise Rochat
Arun T Kamath
Else Marie Agger
Paul-Henri Lambert
P2860
P356
10.1371/JOURNAL.PONE.0005771
P407
P577
2009-06-03T00:00:00Z